EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endothelial TET2 deficiency exacerbates diabetic coronary microvascular dysfunction via CMPK2-mediated mitochondrial impairment

Bo Li, Yefei Shi, Ke Yang, Chang Liu, Qinfang Miao, Kadierya Yibulayin, Zhijun Lei, Bingyu Li, Shiyu Gong, Qing Yu, Jianhui Zhuang, Haikun Qi iD und 2 weitere

Clinical Science · 2026

DOI: 10.1042/cs20256842 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, 2026. Verfasst von Bo Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Diabetic Angiopathies, DNA-Binding Proteins, Dioxygenases, Coronary Vessels. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Chinese National Natural Science Foundation, the Explorer Program of Shanghai Municipality, the Shanghai Municipal Hospital Cardiovascular Specialist Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronary microvascular dysfunction (CMD) is prevalent in diabetes. Ten-eleven translocation-2 (TET2) as the major demethylase in endothelial cells (ECs) is decreased in diabetic CMD, and the role warrants further exploration. In this study, a multi-modality imaging, consist of transthoracic Doppler echocardiography and artery spin labeling cardiac magnetic resonance, is assessed for coronary microvascular function. The expression of TET2 is down-regulated in the heart of diabetic CMD mice. ECs TET2 conditional knockout increases the severity of CMD in diabetic mice. Mechanistically, TET2 deficiency declined the expression of CMPK2, a mtDNA synthetase. Additionally, the mitochondrial electron transport chain complexes encoded by mitochondrial DNA (mtDNA) are down-regulated, which contributes to the excessive production of reactive oxygen species. This, in turn, exacerbated mitochondrial dysfunction, manifesting as mitochondrial membrane potential depolarization, aberrant opening of the mitochondrial permeability transition pore, and structural abnormalities in mitochondria. Therapeutic research demonstrates that vitamin C improves ECs mitochondrial function in diabetic CMD through the TET2–CMPK2 pathway, revealing its potential clinical therapeutic value. In conclusion, we show that loss of endothelial TET2 impairs endothelial mitochondrial function and exacerbated diabetic CMD by regulating the expression of mitochondria enzyme CMPK2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic AngiopathiesDNA-Binding ProteinsDioxygenasesCoronary VesselsNucleoside-Phosphate KinaseDiabetes Mellitus, ExperimentalEndothelial CellsElectron Transport Chain Complex ProteinsMembrane Potential, MitochondrialMitochondriaDown-RegulationAnimalsMiceHuman Umbilical Vein Endothelial CellsHumansMale

Stichwörter der Autor:innen

CMDCMPK2DiabetesMitochondrial functionTET2Vitamin C

Substanzen

Tet2 protein, mouseDNA-Binding ProteinsDioxygenasesCmpk2 protein, mouseNucleoside-Phosphate KinaseElectron Transport Chain Complex ProteinsTET2 protein, humanCMPK2 protein, human

Autor:innen und Institutionen

  • Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Shanghai, China.
  • Department of Endocrinology, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China.
  • Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
  • School of Biomedical Engineering, ShanghaiTech University, Shanghai, China.
  • University of Missouri Health System, Columbia, MO, U.S.A.

ORCID-Profile: Haikun Qi, Wenhui Peng, Weixia Jian

Förderung

  • the Chinese National Natural Science Foundation
  • the Explorer Program of Shanghai Municipality
  • the Shanghai Municipal Hospital Cardiovascular Specialist Alliance

Zitieren

APA

Li, B., Shi, Y., Yang, K., Liu, C., Miao, Q., Yibulayin, K., Lei, Z., Li, B., Gong, S., Yu, Q., Zhuang, J., Qi, H., Peng, W., & Jian, W. (2026). Endothelial TET2 deficiency exacerbates diabetic coronary microvascular dysfunction via CMPK2-mediated mitochondrial impairment. Clinical Science. https://doi.org/10.1042/cs20256842

Vancouver

Li B, Shi Y, Yang K, Liu C, Miao Q, Yibulayin K, et al. Endothelial TET2 deficiency exacerbates diabetic coronary microvascular dysfunction via CMPK2-mediated mitochondrial impairment. Clinical Science. 2026. doi:10.1042/cs20256842

BibTeX
@article{Li2026,
  author = {Li, Bo and Shi, Yefei and Yang, Ke and Liu, Chang and Miao, Qinfang and Yibulayin, Kadierya and Lei, Zhijun and Li, Bingyu and Gong, Shiyu and Yu, Qing and Zhuang, Jianhui and Qi, Haikun and Peng, Wenhui and Jian, Weixia},
  title = {Endothelial TET2 deficiency exacerbates diabetic coronary microvascular dysfunction via CMPK2-mediated mitochondrial impairment},
  journal = {Clinical Science},
  year = {2026},
  doi = {10.1042/cs20256842}
}
Kostenlos starten →